132 related articles for article (PubMed ID: 17325875)
1. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
Nand S; Barton K
Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
[No Abstract] [Full Text] [Related]
2. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
[No Abstract] [Full Text] [Related]
3. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
Cağirgan S; Sencan M; Tombuloglu M; Ozdemir E; Hekimgil M; Büyükkeçeci F
Leuk Lymphoma; 1998 Apr; 29(3-4):423-5. PubMed ID: 9684940
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic granulocytic leukemia in blastic crisis.
Canellos GP
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
[No Abstract] [Full Text] [Related]
5. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
6. Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib.
Kim HJ; Jung CW; Kim K; Ahn JS; Kim WS; Park K; Ko YH; Kang WK; Park K
J Clin Oncol; 2006 Aug; 24(24):4028-9. PubMed ID: 16921058
[No Abstract] [Full Text] [Related]
7. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
[No Abstract] [Full Text] [Related]
8. Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
Curik N; Laznicka A; Polivkova V; Krizkova J; Pokorna E; Semerak P; Suchankova P; Burda P; Hochhaus A; Machova Polakova K
Leukemia; 2024 Jun; 38(6):1415-1418. PubMed ID: 38615117
[No Abstract] [Full Text] [Related]
9. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
10. [The megakaryoblastic variant of the blast crisis in chronic myeloleukemia].
Volkova MA; Frenkel' MA; Lepkov SV; Tupitsyn NN
Ter Arkh; 1990; 62(7):127-9. PubMed ID: 2251650
[No Abstract] [Full Text] [Related]
11. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
12. Long duration priapism in blast crisis of chronic myeloid leukemia.
Dogra PN; Kumar P; Goel R; Dash SC
J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
[No Abstract] [Full Text] [Related]
13. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G
Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319
[No Abstract] [Full Text] [Related]
14. Continuous infusion of mitoxantrone combined with high-dose cytarabine in refractory/relapsed acute myeloblastic leukemia and blast crisis of chronic myelogenous leukemia.
Linkesch W; Thaler J; Gattringer C; Konwalinka G
Haematol Blood Transfus; 1990; 33():330-2. PubMed ID: 2323638
[No Abstract] [Full Text] [Related]
15. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
16. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
[No Abstract] [Full Text] [Related]
17. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
[TBL] [Abstract][Full Text] [Related]
18. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
Kashimura M; Ohyashiki K
Leuk Res; 2010 Aug; 34(8):e213-4. PubMed ID: 20299093
[No Abstract] [Full Text] [Related]
19. Extramedullary relapse of chronic myeloid leukemia in blast crisis: more questions than answers.
Ross DM
Leuk Lymphoma; 2009 Apr; 50(4):517-8. PubMed ID: 19373644
[No Abstract] [Full Text] [Related]
20. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
